MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

1. Monk, B.J.
2. Grisham, R.N.
3. Banerjee, S.
4. Kalbacher, E.
5. Mirza, M.R.
6. Romero, I.
7. Vuylsteke, P.
8. Coleman, R.L.
9. Hilpert, F.
10. Oza, A.M.
11. Westermann, A.
12. Oehler, M.K.
13. Pignata, S.
14. Aghajanian, C.
15. Colombo, N.
16. Drill, E.
17. Cibula, D.
18. Moore, K.N.
19. Christy-Bittel, J.
20. del Campo, J.M.
21. Berger, R.
22. Marth, C.
23. Sehouli, J.
24. O’Malley, D.M.
25. Churruca, C.
26. Boyd, A.P.
27. Kristensen, G.
28. Clamp, A.
29. Ray-Coquard, I.
30. Vergote, I.
31. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.20.01164 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus